Similarly, Li et al.[130] showed that JAK inhibition prevented RANKL‐mediated osteoclastogenesis, and prevented OVX‐induced osteoporosis by suppressing activation of STAT3 and NF‐κB pathways. Here, NFKB1 is linked to osteoporosis.